Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.41
Delayed Data
As of Sep 30
 -0.04 / -0.90%
Today’s Change
1.63
Today|||52-Week Range
12.88
-57.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash21.2M21.3M54.7M30.5M
 
 
 
 
 
Short Term Investment Cash4.4M273.0K33.4M-24.2M
 
 
 
 
 
Cash & Short Term Investments35.9M38.2M72.9M53.2M
 
 
 
 
 
 
ReceivablesReceivables4.6M2.1M6.7M6.2M
 
 
 
 
 
 
InventoriesInventories0.000.00683.0K1.6M
 
 
 
 
Current AssetsOther Current Assets1.1M1.7M9.0M4.9M
 
 
 
 
 
Current Assets41.6M42.0M89.3M65.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross14.9M14.4M14.2M19.4M
 
 
 
 
 
Depreciation-14.3M-14.1M-14.0M-14.2M
 
 
 
 
 
Other Assets14.1M3.9M6.3M5.8M
 
 
 
 
 
Total Assets57.4M48.9M136.9M124.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.0M4.2M2.8M9.3M
 
 
 
 
 
Short Term Debt0.000.0030.0M30.0M
 
 
 
Accrued Expenses2.0M9.6M15.6M22.5M
 
 
 
 
 
Other Current Liabilities3.4M11.1M22.7M24.7M
 
 
 
 
 
Other Liabilities17.2M15.3M57.7M64.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt30.0M30.0M0.002.4M
 
 
 
 
Other Liabilities4.7M0.000.00329.0K
 
 
 
Total Liabilities57.9M50.0M61.2M76.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-454.0K-1.1M75.6M47.7M
 
 
 
 
 
Total Shareholder Equity-454.0K-1.1M75.6M47.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding50.9M59.1M72.0M73.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.